The prevention and treatment of coronary heart disease is a major challenge in the overall
management of the patient with type 2 diabetes. Diabetic dyslipidaemia is an important risk …

PREVIEW Because patients with type 2 diabetes are at high risk for cardiovascular events,
lipid abnormalities in these patients should be aggressively and efficiently treated. What is …

Abstract Purpose of the Review To summarize available evidence regarding lipid-lowering
interventions for the prevention of cardiovascular disease in patients with diabetes. Recent …

In summary the benefits of statin therapy in diabetes has been confirmed and extended such
that the overwhelming majority of diabetic patients should be considered for this therapy …

Dyslipidemias represent a variety of quantitative and/or qualitative lipoprotein abnormalities.
According to etiology, we distinguish primary dyslipidemias with strictly genetic background …

Patients with type 2 diabetes are known to have an elevated risk of cardiovascular morbidity
and mortality. Prior to the development of hyperglycemia and type 2 diabetes, individuals …

Type 2 diabetes is associated with significant cardiovascular morbidity and mortality.
Although low-density lipoprotein cholesterol levels may be normal in patients with type 2 …

Cardiovascular disease is the leading cause of morbidity and mortality in patients with type 2
diabetes mellitus, and dyslipidemia is one of the most important modifiable cardiovascular …

Diabetic dyslipidemia, characterized by the lipid triad (elevated plasma triglycerides, low
HDL cholesterol and predominance of small, dense LDL particles), is a significant …

Zur effektiven Senkung des kardiovaskulären Risikos bei Patienten mit Diabetes ist eine
multimodale Therapie notwendig. Es ist beispielsweise nicht zielführend, den Blutdruck …